CTLT - Catalent postpones quarterly filing as impairment charges hurt results
2023-11-14 06:53:25 ET
More on Catalent
- Catalent Remains Overvalued
- Catalent, Inc. (CTLT) Q4 2023 Earnings Call Transcript
- Catalent, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Catalent gets NYSE notice over late Form 10-K filing
- Argus upgrades Catalent to buy, cites transition to biologics production
For further details see:
Catalent postpones quarterly filing as impairment charges hurt results